Ikena Oncology
(NASDAQ) IKNA
Ikena Oncology Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$50.97M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
IKNA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ikena Oncology
Industry
Pharmaceuticals
Sector
Health CareEmployees
15
CEO
Kristin Yarema, PhD
Website
www.inmagenebio.comHeadquarters
Boston, MA 02210, US
IKNA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-34%
Return on Capital
-39%
Return on Assets
-28%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$48.45M
EBITDA
$48.45M
Operating Cash Flow
$47.84M
Capital Expenditure
$0.00
Free Cash Flow
$47.84M
Cash & ST Invst.
$75.78M
Total Debt
$0.00
Ikena Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$174.00K
-20.5%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
10
N/A
Net Income
$13.95M
-52.9%
EBITDA
$11.76M
+2.7%
Quarterly Fundamentals
Net Cash
$75.78M
-35.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-28.16%
N/A
Return on Invested Capital
-38.55%
N/A
Free Cash Flow
$7.22M
-15.3%
Operating Cash Flow
$7.22M
-15.3%